Geron Corporation (GERN) vs Sana Biotechnology, Inc. (SANA)
- Geron Corporation GERN 1.17 −4.88%
- Sana Biotechnology, Inc. SANA 2.27 −8.47%
Geron Corporation and Sana Biotechnology, Inc. are both Biotechnology companies. Geron Corporation and Sana Biotechnology, Inc. are of similar size ($790.2M and $740.9M). Sana Biotechnology, Inc. has the higher net margin (0.00% vs −33.1%) and the higher return on invested capital (0.00% vs −89.9%). Across the 14 metrics below, Geron Corporation leads on 8 and Sana Biotechnology, Inc. on 6.
Valuation
Profitability
| Metric | GERN | SANA | Biotechnology median |
|---|---|---|---|
| Gross margin | 93.51% | 0.00% | 65.16% |
| Operating margin | (25.31%) | 0.00% | 0.00% |
| Net margin | (33.05%) | 0.00% | 0.00% |
| Free cash flow margin | (56.10%) | 0.00% | 0.00% |
| Return on equity | (28.28%) | (152.87%) | (56.36%) |
| Return on assets | (12.59%) | (53.41%) | (48.04%) |
| Return on invested capital | (89.85%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack